Mark N. Lampert, 10% Owner at Calithera Biosciences, Inc. (CALA), bought 383,908 shares at $3.91 ($1.5M) on 2019-11-20, disclosed to the SEC on 2019-11-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.91 | 14,151 | $55K | 3.7% |
| 2 | $3.91 | 14,151 | $55K | 3.7% |
| 3 | $3.91 | 79,285 | $310K | 20.7% |
| 4 | $3.91 | 79,285 | $310K | 20.7% |
| 5 | $3.91 | 98,518 | $385K | 25.7% |
| 6 | $3.91 | 98,518 |
| $385K |
| 25.7% |
| Total | $3.91 avg | 383,908 | $1.5M | 100% |
| Filing → |
| MRUS | BUY | 2021-03-18 | $5.8M | — | Filing → |
| XOMA | BUY | 2019-12-20 | $8.2M | — | Filing → |
| CALA | BUY | 2019-11-18 | $829K | — | Filing → |